Displaying 145 - 156 items out of 293 results
Press release
… process. In the National Lung Screening Trial (NLST), researchers sought to determine if low-dose CT screening was … study. Now, in the Journal of the Thoracic Oncology , researchers led by Reginald F. Munden MD, DMD, Wake Forest … a multidisciplinary approach and includes original research reviews and opinion pieces. The audience includes …
Press release
… treatment, income levels, and survival outcomes. The research was presented today at the IASLC 2021 World … MPM. To determine an answer, Dr. Rodriguez and his co-researchers used the National Cancer Database to assess … other thoracic malignancies, attracting more than 7,000 researchers, physicians and specialists from more than 100 …
Press release
… Barcelona—Researchers reported today that a prospective trial comparing … PLCOm2012 criteria over the USPSTF criteria,” said lead researcher Stephen Lam, M.D., of the University of British … other thoracic malignancies, attracting more than 7,000 researchers, physicians and specialists from more than 100 …
Press release
… non-small cell lung cancer (NSCLC), according to research presented today at the International Association for … further evaluation. For the purposes of this study, the researchers defined c-Met protein overexpression as greater … and other thoracic malignancies, attracting nearly 7,000 researchers, physicians and specialists from more than 100 …
Press release
… atezolizumab met safety criteria, according to research presented today in OA13: Topics in Pleural … Cancer Center in Houston and her clinical site co-researchers randomly assigned 24 patients with epithelioid or … other thoracic malignancies, attracting more than 7,000 researchers, physicians and specialists from more than 100 …
Press release
… promise as a screening method for MPM, according to research presented today at the International Association for … outcomes and tailor therapies for individual patients, researchers have been exploring predictive markers. Recently, … other thoracic malignancies, attracting more than 7,000 researchers, physicians, and specialists from more than 100 …
Press release
… a broad range of complementary expertise, including research and education (IASLC), diagnostics (Guardant Health), patient advocacy (GLCC), and medicines research and development (AstraZeneca). The founding partners … Project is a collection of clinical trial data and research that can be used to validate surrogate endpoints and …
Press release
… published today in the Journal of Thoracic Oncology , researchers from France showed that SARS-CoV2 vaccines are … University Hospital Bichat-Claude Bernard in Paris. The researchers enrolled 306 patients with lung cancer, with a … a multidisciplinary approach and includes original research reviews and opinion pieces. The audience includes …
Press release
… could benefit from targeted therapies, according to research presented today at the IASLC 2019 World Conference on … that have the strongest potential for further research. Middleton and his colleagues recruited 315 patients … other thoracic malignancies, attracting more than 7,000 researchers, physicians and specialists from more than 100 …
Press release
… for the design of new clinical trials, according to research presented today at the IASLC 2021 World Conference on … chemoimmunotherapy with nivolumab, Dr. Romero and her co-researchers evaluated the capacity of ctDNA levels before … other thoracic malignancies, attracting more than 7,000 researchers, physicians and specialists from more than 100 …
Press release
… abstinence rates of more than 30 percent, according to research presented today at the IASLC World Conference on Lung … of a personalized approach, United Kingdom-based researchers developed the Yorkshire Enhanced Stop Smoking … other thoracic malignancies, attracting more than 7,000 researchers, physicians and specialists from more than 100 …
Press release
… who received these therapies concurrently, according to research presented today at the IASLC World Conference on Lung … pembrolizumab as a potential first-line treatment.” The researchers enrolled 58 KRAS G12C inhibitor-naïve patients … other thoracic malignancies, attracting more than 7,000 researchers, physicians and specialists from more than 100 …